Iva Hauptmannova

Iva Hauptmannova joined Humanimal Trust in a freelance research support role in the autumn of 2022, embracing the opportunity to translate her experience and lifelong passion into supporting the work of the Trust. She graduated with BSc (Hons) from University of Westminster in 2002 and received a Master’s degree from King’s College London in 2003.

She has worked in various roles within human clinical research for almost 20 years and has supported the development of national research strategies. She has contributed to securing funding and the delivery of large scale national and international trials in orthopaedics and rare bone diseases. She has extensive experience in many areas of clinical research from supporting project design and grant applications, to project feasibility, commercial development to regulatory submissions and project delivery to strategy development and delivery.

She has developed successful partnershipswith academic institutions as well as commercial organisations. In recent years, she has been a member of the UK Genome 100,000 Oversight Board, the UK R&D Leadership Group, National Spinal Cord Injuries Research Group as well as several committees supporting the development of UK research infrastructure.

Until recently, she was the Head of Research & Innovation Centre at the Royal National Orthopaedic Hospital NHS Trust, also holding an honorary senior research associate position at University College London.

“To me, One Medicine is about sharing knowledge and saving lives—but it’s also so much more than that. While I fully stand by our formal definition, I see One Medicine as something deeper: the missing piece of One Health.
It challenges the anthropocentric view of the world and recognises the value of all life, regardless of species. The survival of our planet depends not just on protecting human health, but on benefiting all species. We are all animals, part of the same natural world, and we all deserve access to the advances of science and innovation.
As is often quoted, the mark of a civilisation is how it treats those who cannot speak for themselves. One Medicine is our opportunity to live by that principle—to ensure we don’t just heal those who can afford care, but everyone who needs it, because we value all life.
I know the world is driven by economics, and innovation often follows investment. But that makes it even more important to broaden our vision. When we build systems that value all life, we open new pathways for research, collaboration, and sustainable impact.”
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.